Dr. Munia Ganguli is a Senior Principal Scientist at the CSIR-Institute of Genomics and Integrative Biology (IGIB), India working on Nanobiotechnology and its therapeutic applications. One of the primary focus areas is delivery of nucleic acids to organs like skin and lungs using designed cell penetrating peptides. In addition, the laboratory also works on application of functionalized organic and inorganic nanoparticles for a wide variety of applications ranging from UV protection to cancer drug delivery. Her group has developed different cationic and amphipathic peptide based nanocomplexes with a range of surface modifications for gene delivery to multiple cell types including skin, lung and eye. Currently the focus is also on developing delivery systems for ribonucleoprotein complexes for efficient CRISPR-Cas9 based gene editing. Dr. Ganguli is a member of the contingent which represented IGIB in the Joint Research Initiative between CSIR and IGIB for interfacing chemistry with biology and has been a member of the editorial advisory committee of Nano Science and its Application, a national level seminar sponsored by the University Grants Commission. She has been the leader of the IGIB project, Nanomaterials and nanodevices for applications in health and disease, has delivered invited speeches which included the International Conference on Advances in Biological Systems and Materials Science in NanoWorld (ABSMSNW-2017) and guest edited the special volume of Science and Culture journal on Emerging Trends in Genomics : Applications in Health and Disease, published in January 2011. The Department of Biotechnology of the Government of India awarded her the National Bioscience Award for Career Development, one of the highest Indian science awards, for her contributions to biosciences, in 2012.